Next year could bring the most significant changes to the U.S. Food and Drug Administration in recent memory if Sen. Charles Grassley (R-IA) and Rep. John Dingell's (D-MI) plans come to pass, according to a news analysis.

Attendees at the International Conference on Alzheimer's Disease in Chicago last week heard some exciting news: Scientists have been able to halt the progression of Alzheimer's during a recent clinical drug trial.

While the number of Medicare Part D program complaints has fallen since the program began, the Centers for Medicare & Medicaid Services still has problems resolving critical program complaints.

The use of blood-pressure drugs is linked to a lower incidence of Alzheimer's disease and a reduced likelihood of entering a nursing home, Boston University School of Medicine researchers found.

The Department of Health and Human Services has announced a new incentive program to help spur the advancement of electronic prescribing practices.

Researchers are questioning the effectiveness of bone-building drugs used to fight osteoporosis, saying they might weaken bones in a subset of patients.

Seniors who take four or more prescription medications have two to three times the risk of falling as seniors who take fewer meds, according to researchers at the University of North Carolina. Some of those drugs, the researchers say, may actually contribute to the risk of falling.

Palliative care workers are allowed to sedate some patients with intractable pain at the end of life--but only as a last-resort measure, according to a new ethical guideline approved by the American Medical Association at its most recent annual meeting.

The Food and Drug Administration disapproved 96% of applications for generic drug approval in 2006, according to a report recently released from the Health and Human Services Office of the Inspector General.

The American Society of Consultant Pharmacists (ASCP) this week announced the launch of ASCP Ventures, Inc., a for-profit subsidiary of ASCP.